Quetiapine Tablet, Film Coated
Product Images NDC 16729-146

9 FDA label images from Accord Healthcare Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 16729-146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine Tablets 100 mg (Quetiapine 100mg 30)

Quetiapine Tablets 100 mg (Quetiapine 100mg 30)
Label for Quetiapine Tablets, USP 100 mg by Accord Healthcare Inc. The label indicates 30 film-coated tablets for prescription use only. Manufactured by Intas Pharmaceuticals Limited, India, and includes storage instructions and pharmacist dispensing guidance. The label shows NDC 16729-147-10 and includes barcode and blank space for lot and expiration data.*
FDA Label Image

Quetiapine Tablets 200 mg (Quetiapine 200mg 30)

Quetiapine Tablets 200 mg (Quetiapine 200mg 30)
Label for Quetiapine Tablets, USP 200 mg, film coated tablets manufactured by Intas Pharmaceuticals Limited and labeled by Accord Healthcare Inc. The package contains 30 tablets. The label includes storage instructions and a warning to keep out of reach of children. It also states 'Rx Only' and advises pharmacists to dispense the enclosed Medication Guide.*
FDA Label Image

Quetiapine Tablets 25 mg (Quetiapine 25mg 30)

Quetiapine Tablets 25 mg (Quetiapine 25mg 30)
Packaging label for Quetiapine Tablets, USP 25 mg film coated tablets by Accord Healthcare Inc. The label includes the NDC 16729-145-10 and indicates a quantity of 30 tablets. It states the drug is prescription only and contains storage and dispensing instructions. Manufacturer information is provided for Intas Pharmaceuticals Limited, India, and Accord Healthcare, Durham, NC.*
FDA Label Image

Quetiapine Tablets 300 mg (Quetiapine 300mg 30)

Quetiapine Tablets 300 mg (Quetiapine 300mg 30)
Packaging label for Quetiapine Tablets, USP 300 mg film-coated tablets. The label shows it is a prescription drug supplied in a bottle containing 30 tablets. Manufactured for Accord Healthcare Inc. and by Intas Pharmaceuticals Limited, India. Includes storage instructions and pharmacist dispensing note.*
FDA Label Image

Quetiapine Tablets 400 mg (Quetiapine 400mg 30)

Quetiapine Tablets 400 mg (Quetiapine 400mg 30)
Label for Quetiapine Tablets, USP 400 mg film-coated tablets by Accord Healthcare Inc. The label indicates the product is Rx only and provides storage instructions along with manufacturer information. This package contains 30 tablets and includes NDC 16729-150-10.*
FDA Label Image

Quetiapine Tablets 50 mg (Quetiapine 50mg 30)

Quetiapine Tablets 50 mg (Quetiapine 50mg 30)
Label for Quetiapine Tablets, USP 50 mg film-coated tablets manufactured by Intas Pharmaceuticals and labeled by Accord Healthcare Inc. The label indicates prescription use (Rx Only) with a package count of 30 tablets. Storage instructions and warnings about keeping out of reach of children and recommended temperature are included, along with a medication guide notice for pharmacists.*
FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)
A line graph showing the proportion of patients with relapse (%) over time (weeks) for two treatment groups labeled QTP + LIVAL and PLA + LIVAL. The x-axis represents time in weeks from 0 to 100, and the y-axis represents the proportion of patients with relapse from 0% to 100%. Two curves illustrate how relapse rates change over time for each group.*
FDA Label Image

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)
A Kaplan-Meier curve chart showing the proportion of patients with relapse (%) over time (weeks) comparing two treatments: QTP + LIVAL (Quetiapine plus Lithium or Valproate) and PLA + LIVAL (Placebo plus Lithium or Valproate). The chart tracks patient relapse proportions from 0 to 100 weeks, with PLA + LIVAL showing a higher relapse rate over time compared to QTP + LIVAL.*
FDA Label Image

Chemstructure (Quetiapine Str)

Chemstructure (Quetiapine Str)
Chemical structure of the active ingredient quetiapine, shown alongside a chemical structure of an associated component or salt form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.